Lauren E Haydu

Lauren E Haydu

UNVERIFIED PROFILE

Are you Lauren E Haydu?   Register this Author

Register author
Lauren E Haydu

Lauren E Haydu

Publications by authors named "Lauren E Haydu"

Are you Lauren E Haydu?   Register this Author

79Publications

2036Reads

50Profile Views

Telementoring and smartphone-based answering systems to optimize dermatology resident dermoscopy education.

J Am Acad Dermatol 2019 Aug 29;81(2):e27-e28. Epub 2019 Jan 29.

Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.01.045DOI Listing
August 2019

Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression.

J Invest Dermatol 2019 Jun 7. Epub 2019 Jun 7.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2019.03.1158DOI Listing
June 2019

Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

J Neurooncol 2019 May 7;142(3):499-509. Epub 2019 Mar 7.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03121-2DOI Listing
May 2019

Embracing changes to the American Joint Committee on Cancer 8th edition melanoma staging system.

Eur J Cancer 2019 May 15;112:9-11. Epub 2019 Mar 15.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.01.103DOI Listing
May 2019

Subungual Melanoma of the Hand.

Ann Surg Oncol 2019 Apr 18;26(4):1035-1043. Epub 2018 Dec 18.

Melanoma Institute Australia, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-018-07094-wDOI Listing
April 2019

Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma.

J Invest Dermatol 2019 Mar 25;139(3):728-731. Epub 2018 Oct 25.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2018.10.009DOI Listing
March 2019

Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in -Mutant Melanoma.

JCO Precis Oncol 2018 5;2018. Epub 2018 Jun 5.

Junna Oba, Sun-Hee Kim, Wei-Lien Wang, Mariana P. Macedo, Fernando Carapeto, Meredith A McKean, John Van Arnam, Agda K. Eterovic, Shiraj Sen, Charuta R. Kale, Xiaoxing Yu, Cara L. Haymaker, Mark Routbort, Lauren E. Haydu, Chantale Bernatchez, Alexander J. Lazar, Elizabeth A. Grimm, David S. Hong, and Scott E. Woodman, The University of Texas MD Anderson Cancer Center, Houston, TX; and Mariana P. Macedo, AC Camargo Cancer Center, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080631PMC
http://dx.doi.org/10.1200/PO.18.00055DOI Listing
June 2018

Conditional survival estimates for cancer patients.

Oncotarget 2017 Oct 4;8(49):84639-84640. Epub 2017 Oct 4.

John F. Thompson: Melanoma Institute Australia, The University of Sydney, and Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21497DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689561PMC
October 2017

Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes.

J Invest Dermatol 2017 08 23;137(8):1792-1795. Epub 2017 Apr 23.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.04.007DOI Listing
August 2017

Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis.

J Clin Oncol 2017 May 4;35(15):1721-1729. Epub 2017 Apr 4.

Lauren E. Haydu, Richard A. Scolyer, Serigne Lo, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, and John F. Thompson: The University of Sydney, Sydney; Richard A. Scolyer, Robyn P.M. Saw, and John F. Thompson, Royal Prince Alfred Hospital, Camperdown; Michael J. Quinn, The University of Wollongong, Wollongong, NSW, Australia; and Lauren E. Haydu, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.9393DOI Listing
May 2017

Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases.

Ann Surg Oncol 2015 11;22(6):1959-66. Epub 2014 Nov 11.

Melanoma Institute Australia (formerly the Sydney Melanoma Unit), North Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-4215-3DOI Listing
February 2016

The molecular profile of metastatic melanoma in Australia.

Pathology 2016 Feb 18;48(2):188-93. Epub 2016 Jan 18.

Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2015.12.008DOI Listing
February 2016

PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma Patients.

Clin Cancer Res 2015 Jul 21;21(14):3140-8. Epub 2015 Jan 21.

Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2023DOI Listing
July 2015

Sex differences in melanoma survival are not related to mitotic rate of the primary tumor.

Ann Surg Oncol 2015 May 19;22(5):1598-603. Epub 2014 Nov 19.

Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-4166-8DOI Listing
May 2015

Targeted BRAF inhibition impacts survival in melanoma patients with high levels of Wnt/β-catenin signaling.

PLoS One 2014 14;9(4):e94748. Epub 2014 Apr 14.

Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0094748PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986217PMC
January 2015

The optimum excision margin and regional node management for primary cutaneous T3 melanomas (2-4 mm in Thickness): a retrospective study of 1587 patients treated at a single center.

Ann Surg 2014 Dec;260(6):1095-102

*Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands †Melanoma Institute Australia, Sydney, New South Wales, Australia Disciplines of ‡Surgery, and §Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; and ¶Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000000792DOI Listing
December 2014

The impact of socioeconomic status on melanoma clinical trial participation: an observational cohort study from Australia.

Melanoma Manag 2014 Nov 4;1(2):95-103. Epub 2014 Dec 4.

School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/mmt.14.17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094633PMC
November 2014

The nature and management of metastatic melanoma after progression on BRAF inhibitors: effects of extended BRAF inhibition.

Cancer 2014 Oct 1;120(20):3142-53. Epub 2014 Jul 1.

Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28851DOI Listing
October 2014

Features and management of pyrexia with combined dabrafenib and trametinib in metastatic melanoma.

Melanoma Res 2014 Oct;24(5):468-74

aWestmead Hospital bWestmead Institute for Cancer Research, Westmead cMelanoma Institute Australia dSydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000110DOI Listing
October 2014

Reply to M. Perier-Muzet et al.

J Clin Oncol 2014 Oct 2;32(28):3203. Epub 2014 Sep 2.

Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.8477DOI Listing
October 2014

A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.

Mod Pathol 2014 Aug 3;27(8):1088-100. Epub 2014 Jan 3.

Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven (KU Leuven), Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.228DOI Listing
August 2014

Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.

Ann Surg 2014 Jul;260(1):149-57

*Melanoma Institute Australia †Sydney Medical School, The University of Sydney, Sydney ‡Nuclear Medicine and Diagnostic Ultrasound, RPAH Medical Centre, Newtown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000000500DOI Listing
July 2014

BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact.

Clin Cancer Res 2014 Apr 24;20(7):1965-77. Epub 2014 Jan 24.

Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3122DOI Listing
April 2014

Low incidence of melanoma brain metastasis in the hippocampus.

Radiother Oncol 2014 Apr 20;111(1):59-62. Epub 2014 Feb 20.

Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Genesis Cancer Care, Mater Hospital, North Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2014.01.012DOI Listing
April 2014

Incidence of new primary melanomas after diagnosis of stage III and IV melanoma.

J Clin Oncol 2014 Mar 2;32(8):816-23. Epub 2013 Dec 2.

Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.5572DOI Listing
March 2014

Genetic and clinico-pathologic analysis of metastatic uveal melanoma.

Mod Pathol 2014 Feb 26;27(2):175-83. Epub 2013 Jul 26.

1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.138DOI Listing
February 2014

Patterns of response and progression in patients with BRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib.

Cancer 2014 Feb 5;120(4):530-6. Epub 2013 Nov 5.

Westmead Hospital, Westmead, Australia; Melanoma Institute Australia, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28445DOI Listing
February 2014

Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden.

Ann Surg Oncol 2014 Jan 20;21(1):292-9. Epub 2013 Sep 20.

Sydney Medical School, The University of Sydney, Sydney, Australia,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-013-3253-6DOI Listing
January 2014

Reproducibility of AJCC staging parameters in primary cutaneous melanoma: an analysis of 4,924 cases.

Ann Surg Oncol 2013 Nov 13;20(12):3969-75. Epub 2013 Jul 13.

Melanoma Institute Australia, North Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-013-3092-5DOI Listing
November 2013

Margins of excision and prognostic factors for cutaneous eyelid melanomas.

J Plast Reconstr Aesthet Surg 2013 Aug 17;66(8):1066-73. Epub 2013 May 17.

Department of Melanoma & Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bjps.2013.04.032DOI Listing
August 2013

Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma.

Ann Surg Oncol 2012 Oct 21;19(11):3325-34. Epub 2012 Jul 21.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-012-2509-xDOI Listing
October 2012

Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma.

Radiat Oncol 2012 Oct 17;7:171. Epub 2012 Oct 17.

Faculty of Medicine, University of New South Wales, Botany Street, Sydney, NSW, 2052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1748-717X-7-171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494567PMC
October 2012

Is melphalan dose adjustment according to ideal body weight useful in isolated limb infusion for melanoma?

Ann Surg Oncol 2012 Sep 24;19(9):3050-6. Epub 2012 Apr 24.

Melanoma Institute Australia, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-012-2316-4DOI Listing
September 2012

Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.

Clin Cancer Res 2012 Jun 24;18(12):3242-9. Epub 2012 Apr 24.

Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-12-0052DOI Listing
June 2012

Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.

Ann Surg 2012 Jun;255(6):1165-70

Department of Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0b013e31824c4b0bDOI Listing
June 2012

Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.

Ann Surg Oncol 2012 Jan 21;19(1):280-6. Epub 2011 Jul 21.

Royal North Shore Hospital, St. Leonards, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-011-1872-3DOI Listing
January 2012

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

Ann Surg 2012 Jan;255(1):128-33

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0b013e3182306c72DOI Listing
January 2012

Ultrasound assessment of lymph nodes in the management of early-stage melanoma.

J Surg Oncol 2011 Sep;104(4):354-60

Sydney Medical School, The University of Sydney, NSW Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21963DOI Listing
September 2011

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

J Clin Oncol 2011 Apr 22;29(10):1239-46. Epub 2011 Feb 22.

Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.32.4327DOI Listing
April 2011